AI Analysis AI Analysis of NXTC AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add NXTC to Watchlist?
  • Easy Tracking In The Watchlist
PDF

High volatility in NextCure Inc. stock price on Friday which ended trading at $1.65
(Updated on Jun 26, 2026)

Sell candidate since May 22, 2026 Loss -78.93%

The NextCure Inc. stock price fell by -0.303% on the last day (Friday, 26th Jun 2026) from $1.65 to $1.65. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 12.93% from a day low at $1.59 to a day high of $1.79. The price has fallen in 8 of the last 10 days and is down by -26.23% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -89 thousand shares and in total, 0 shares were bought and sold for approximately $0 .

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $1.46 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -66.82% during the next 3 months and, with a 90% probability hold a price between $0.486 and $1.90 at the end of this 3-month period.

NXTC Signals & Forecast

There are mixed signals in the stock today. The NextCure Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.84 and $5.30. A break-up above any of these levels will issue buy signals. Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". A buy signal was issued from a pivot bottom point on Thursday, June 25, 2026, and so far it has fallen 0%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for NextCure Inc. stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.240 between high and low, or 15.48%. For the last week the stock has had daily average volatility of 16.43%.

NextCure Inc. is oversold on RSI14 (16). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (NXTC) For The Upcoming Trading Day Of Monday 29th

For the upcoming trading day on Monday, 29th we expect NextCure Inc. to open at $1.66, and during the day (based on 14 day Average True Range), to move between $1.36 and $1.94, which gives a possible trading interval of +/-$0.577 (+/-42.40%) up or down from last closing price. If NextCure Inc. takes out the full calculated possible swing range there will be an estimated 42.40% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $1.75, some $0.100 (6.06%) from the current price of $1.65, our system finds the risk reward not very attractive.

Is NextCure Inc. stock A Buy?

NextCure Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

Current score: -4.287 Sell Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on June 29, 2026 - $1.66 ( 0.81%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

NXTC Performance

Trading levels for NXTC

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 1.90 15.35%
R2 1.81 9.80%
R1 1.76 6.36%
Price 1.65
S1 1.57 -4.75%
S2 1.52 -8.18%
S3 1.42 -13.74%

Accumulated Volume Support & Resistance Levels

Level Price
R3 1.96 18.79%
R2 1.81 9.70%
R1 1.75 6.06%
Price 1.65
S1 0 -
S2 0 -
S3 0 -

FAQ

What is the symbol for NextCure Inc. Stock and on which exchange is it traded?
The symbol for NextCure Inc. is NXTC and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell NextCure Inc. Stock?
NextCure Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

How to buy NextCure Inc. Stock?
NextCure Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy NextCure Inc. Stock.

What's the current price of NextCure Inc. Stock?
As of the end of day on the Jun 26, 2026, the price of an NextCure Inc. (NXTC) share was $1.65.

What is the 52-week high and low for NextCure Inc. Stock?
The 52-week high for NextCure Inc. Stock is $15.74 and the 52-week low is $0.390.

What is the market capitalization of NextCure Inc. Stock?
As of the Jun 26, 2026, the market capitalization of NextCure Inc. is 4.408M.

When is the next earnings date for NextCure Inc.?
The upcoming earnings date for NextCure Inc. is Aug 06, 2026.
Click to get the best stock tips daily for free!
ABOUT NEXTCURE INC.
NextCure
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase II clinical trials for the treatment of advanced or metastatic solid tumors. The company is also developing NC410, which is in Phase I for novel immunomedicine designed to block immune sup...
GOLDEN STAR
Ticker Change Signal Date
JLL
$299.78
5.10% Jun 24
X
XMAX
$8.34
5.40% Jun 24
TWI
$7.56
6.08% Jun 22
IAC
$42.63
5.08% Jun 12
DHI
$146.71
13.35% Jun 10

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE